Back to Search
Start Over
The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2014 Dec; Vol. 55 (12), pp. 2935-7. Date of Electronic Publication: 2014 May 06. - Publication Year :
- 2014
- Subjects :
- Antineoplastic Agents administration & dosage
Antineoplastic Agents economics
Benzamides administration & dosage
Benzamides economics
Chemistry, Pharmaceutical
Cost-Benefit Analysis
Drug Substitution
Humans
Imatinib Mesylate
Piperazines administration & dosage
Piperazines economics
Protein Kinase Inhibitors administration & dosage
Protein Kinase Inhibitors economics
Pyrimidines administration & dosage
Pyrimidines economics
Antineoplastic Agents therapeutic use
Benzamides therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Piperazines therapeutic use
Protein Kinase Inhibitors therapeutic use
Pyrimidines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 55
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Editorial & Opinion
- Accession number :
- 24650055
- Full Text :
- https://doi.org/10.3109/10428194.2014.905774